CN114028517A - Fukangtong pill for women - Google Patents
Fukangtong pill for women Download PDFInfo
- Publication number
- CN114028517A CN114028517A CN202110617724.0A CN202110617724A CN114028517A CN 114028517 A CN114028517 A CN 114028517A CN 202110617724 A CN202110617724 A CN 202110617724A CN 114028517 A CN114028517 A CN 114028517A
- Authority
- CN
- China
- Prior art keywords
- blood
- pill
- fukangtong
- basis
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006187 pill Substances 0.000 title claims abstract description 21
- 206010061218 Inflammation Diseases 0.000 claims abstract description 23
- 230000004054 inflammatory process Effects 0.000 claims abstract description 23
- 206010046798 Uterine leiomyoma Diseases 0.000 claims abstract description 14
- 208000002495 Uterine Neoplasms Diseases 0.000 claims abstract description 7
- 206010046766 uterine cancer Diseases 0.000 claims abstract description 7
- 208000000509 infertility Diseases 0.000 claims abstract description 4
- 230000036512 infertility Effects 0.000 claims abstract description 4
- 231100000535 infertility Toxicity 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 27
- 229940079593 drug Drugs 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000237502 Ostreidae Species 0.000 claims description 7
- 208000031513 cyst Diseases 0.000 claims description 7
- 235000020636 oyster Nutrition 0.000 claims description 7
- 241000131329 Carabidae Species 0.000 claims description 6
- 206010011732 Cyst Diseases 0.000 claims description 6
- 239000004863 Frankincense Substances 0.000 claims description 6
- 241000270666 Testudines Species 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 5
- 240000007551 Boswellia serrata Species 0.000 claims description 5
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 5
- 240000009138 Curcuma zedoaria Species 0.000 claims description 5
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 240000009022 Smilax rotundifolia Species 0.000 claims description 5
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims description 5
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims description 5
- 235000019509 white turmeric Nutrition 0.000 claims description 5
- 240000001659 Oldenlandia diffusa Species 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000009910 sargent gloryvine Substances 0.000 claims description 4
- 241000288784 Barleria cristata Species 0.000 claims description 3
- 240000007311 Commiphora myrrha Species 0.000 claims description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 3
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 244000164480 Curcuma aromatica Species 0.000 claims description 3
- 241000241550 Cyathula Species 0.000 claims description 3
- 241000096284 Gynochthodes officinalis Species 0.000 claims description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 3
- 241000972673 Phellodendron amurense Species 0.000 claims description 3
- 240000003152 Rhus chinensis Species 0.000 claims description 3
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 3
- 241000915604 Scutellaria barbata Species 0.000 claims description 3
- 241000246044 Sophora flavescens Species 0.000 claims description 3
- 241000205578 Thalictrum Species 0.000 claims description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 3
- 244000116484 Inula helenium Species 0.000 claims description 2
- 235000002598 Inula helenium Nutrition 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 229940107666 astragalus root Drugs 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229920002261 Corn starch Polymers 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 229940126680 traditional chinese medicines Drugs 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 63
- 239000008280 blood Substances 0.000 abstract description 63
- 230000000694 effects Effects 0.000 abstract description 41
- 201000010099 disease Diseases 0.000 abstract description 31
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 31
- 206010028980 Neoplasm Diseases 0.000 abstract description 23
- 208000002193 Pain Diseases 0.000 abstract description 22
- 230000036407 pain Effects 0.000 abstract description 22
- 201000011510 cancer Diseases 0.000 abstract description 17
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 208000026435 phlegm Diseases 0.000 abstract description 13
- 210000003734 kidney Anatomy 0.000 abstract description 12
- 230000004087 circulation Effects 0.000 abstract description 8
- 239000000463 material Substances 0.000 abstract description 8
- 230000001717 pathogenic effect Effects 0.000 abstract description 8
- 230000007812 deficiency Effects 0.000 abstract description 5
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 238000009499 grossing Methods 0.000 abstract description 3
- 206010061692 Benign muscle neoplasm Diseases 0.000 abstract description 2
- 201000004458 Myoma Diseases 0.000 abstract description 2
- 210000003754 fetus Anatomy 0.000 abstract description 2
- 208000025661 ovarian cyst Diseases 0.000 abstract description 2
- 230000014509 gene expression Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 27
- 210000004291 uterus Anatomy 0.000 description 12
- 206010042674 Swelling Diseases 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000003213 activating effect Effects 0.000 description 8
- 231100000331 toxic Toxicity 0.000 description 8
- 230000002588 toxic effect Effects 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000005906 menstruation Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 241001061264 Astragalus Species 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 235000006533 astragalus Nutrition 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000004233 talus Anatomy 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 201000010260 leiomyoma Diseases 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 208000010579 uterine corpus leiomyoma Diseases 0.000 description 4
- 201000007954 uterine fibroid Diseases 0.000 description 4
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 3
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 3
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 3
- 229910001369 Brass Inorganic materials 0.000 description 3
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 3
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 3
- 239000010951 brass Chemical class 0.000 description 3
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 3
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- -1 glutamic acid Chemical class 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000015500 sitosterol Nutrition 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 244000272264 Saussurea lappa Species 0.000 description 2
- 235000006784 Saussurea lappa Nutrition 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 210000004246 corpus luteum Anatomy 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- LQERIDTXQFOHKA-UHFFFAOYSA-N nonadecane Chemical compound CCCCCCCCCCCCCCCCCCC LQERIDTXQFOHKA-UHFFFAOYSA-N 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- KDPFMRXIVDLQKX-ISGXEFFDSA-N (+)-Curdione Natural products CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)/CC1=O KDPFMRXIVDLQKX-ISGXEFFDSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- HRYLQFBHBWLLLL-UHFFFAOYSA-N (+)-costunolide Natural products C1CC(C)=CCCC(C)=CC2OC(=O)C(=C)C21 HRYLQFBHBWLLLL-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- XZRVRYFILCSYSP-OAHLLOKOSA-N (-)-beta-bisabolene Chemical compound CC(C)=CCCC(=C)[C@H]1CCC(C)=CC1 XZRVRYFILCSYSP-OAHLLOKOSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- KNOUERLLBMJGLF-UHFFFAOYSA-N 1-bisabolone Natural products CC(C)=CCCC(C)C1CCC(C)=CC1=O KNOUERLLBMJGLF-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008671 Calycanthus floridus Nutrition 0.000 description 1
- 244000025311 Calycanthus occidentalis Species 0.000 description 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000004310 Cinnamomum zeylanicum Nutrition 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- CUGKULNFZMNVQI-UHFFFAOYSA-N Costunolid I Natural products CC1=CCC=C(/C)CCC2C(C1)OC(=O)C2=C CUGKULNFZMNVQI-UHFFFAOYSA-N 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WKSUCCVMYJRMFR-UHFFFAOYSA-N Dehydrocostus lactone Natural products C12OC(=O)C(=C)C2CCC(=C)C2(C)C1(C)C(=C)CC2 WKSUCCVMYJRMFR-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 206010061977 Genital infection female Diseases 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- KDPFMRXIVDLQKX-NHFJXKHHSA-N Germacr-1(10)-ene-5,8-dione Chemical compound CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)\CC1=O KDPFMRXIVDLQKX-NHFJXKHHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 206010018762 Grunting Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 235000004520 Lindera benzoin Nutrition 0.000 description 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000157511 Oldenlandia Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000007824 aliphatic compounds Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- HRYLQFBHBWLLLL-AHNJNIBGSA-N costunolide Chemical compound C1CC(/C)=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]21 HRYLQFBHBWLLLL-AHNJNIBGSA-N 0.000 description 1
- MMTZAJNKISZWFG-UHFFFAOYSA-N costunolide Natural products CC1CCC2C(CC(=C/C=C1)C)OC(=O)C2=C MMTZAJNKISZWFG-UHFFFAOYSA-N 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- KDPFMRXIVDLQKX-UHFFFAOYSA-N curdione Natural products CC(C)C1CC(=O)C(C)CCC=C(C)CC1=O KDPFMRXIVDLQKX-UHFFFAOYSA-N 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- NETSQGRTUNRXEO-XUXIUFHCSA-N dehydrocostus lactone Chemical compound C([C@H]1C(=C)C(=O)O[C@@H]11)CC(=C)[C@H]2[C@@H]1C(=C)CC2 NETSQGRTUNRXEO-XUXIUFHCSA-N 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 description 1
- 229960001625 furazolidone Drugs 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Animal Husbandry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Gynecological inflammation, ovarian cyst, uterine myoma, or uterine cancer, and infertility due to cold womb, which are common gynecological diseases. The inventor develops the Fukangtong bao pill with good treatment effect, and shows that the 'Tong' is the key for treating the disease, the inflammation is eliminated, the myoma is small, the cancer is lightened, and the cold is dispersed, qi and blood are harmonized, so that the fetus can be naturally pregnant, and the Fukangtong pill is named as the Fukangtong bao pill. Pain is caused by obstruction, some think of congealing cold, some think of blood stasis and some think of kidney deficiency, and each of the actual expressions has some sidedness, and the curative effect is naturally obvious only by grasping the essence of the disease. The principle of eliminating pathogenic factors, smoothing circulation and removing toxicity is that the circulation of yin and blood in a human body is the most important material basis of the human body and should be called as the basis, blood stasis, phlegm dampness and pathogenic toxin are the targets, and the targets and the basis are often influenced mutually, so that qi and blood circulation is blocked, pathogenic factors accumulate for a long time and the disease is the basis, and therefore the key for treating the disease is to mainly eliminate pathogenic factors, smooth and remove toxicity, and strengthen the body resistance and consolidate the basis.
Description
The Fukangtongbao pill is prepared by the following components according to the formula through years of clinical experiments and continuous exploration, research and improvement: 7 g of roasted turtle shell, 60 g of oyster, 50 g of concha arcae, 50 g of astragalus, 60 g of angelica, 60 g of morinda officinalis, 50 g of frankincense, 40 g of myrrh, 40 g of rhizoma sparganii, 40 g of curcuma zedoary, 50 g of radix linderae, 60 g of elecampane, 30 g of medicinal cyathula root, 20 g of ground beetle, 40 g of gallnut, 30 g of sargentgloryvine stem, 30 g of glabrous greenbrier rhizome, 30 g of philippine violet herb, 30 g of meadowrue root and rhizome, 20 g of barbed skullcap herb, 30 g of spreading hedyotis herb, 50 g of sophora flavescens, 50 g of phellodendron bark and the like. The formula has the functions of nourishing yin and tonifying yang, tonifying qi and nourishing blood, softening hardness and resolving masses, promoting qi circulation and activating blood, promoting diuresis and reducing phlegm, removing turbidity and detoxifying and the like. According to the effects, the traditional Chinese medicine composition can effectively treat gynecological inflammation, infertility caused by cold womb, ovarian cyst, uterine fibroid, uterine cancer and other chronic diseases. What are the major symptoms of the most common of these diseases? The main symptoms are irregular menstruation or menostaxis, amenorrhea, dysmenorrheal, or distending pain of lower abdomen, a large amount of white belt or yellow belt with peculiar smell when being pressed, the lower abdomen often feels cold, the hands and feet are not warm, lumbago, or the legs feel cold and are afraid of wind or numb, the legs are heavy and powerless when walking, qi and blood are insufficient, the sleep is not good, and the like.
The pathological mechanism of the diseases is that Chinese medicine considers that the balance of yin and yang, the harmonization of qi and blood, the circulation and the circulation are the key points for maintaining the health of human bodies. When yin and yang are out of balance and qi and blood are insufficient due to various reasons, blood runs slowly and is blocked, so that phlegm dampness, blood stasis, pathogenic microorganisms and bacteria or various viruses enter the uterus in a deficiency mode, and the toxin of the blood stasis, the phlegm dampness and turbid yin is accumulated in the uterus, so that the diseases are caused and developed. This phlegm-damp and turbid-yin toxicity can also block yang-qi, or the focus of infection compresses blood vessels or affects nerves, so that the yang-qi of the human body is damaged, and even the qi and blood are insufficient, so that the immunity of the human body is reduced, the disease is aggravated, and if the toxicity of the focus of infection is large and is not healed for a long time, local cell genes are degenerated to become cancer cells, and finally the cancer cells are transformed into cancer.
The preparation method of the Fukangtong pill is not complicated, firstly, the medicines are prepared according to the proportion of the formula, then the medicines are pulverized into fine powder of 200 meshes by a pulverizer, then a proper amount of starch adhesive is added, the mixture is fully and uniformly stirred, the uniformly stirred fine powder is prepared into water pills by a full-automatic pill making machine, and then the prepared water pills are dried by a dryer. When the medicine is used for treating a patient, the medicine is taken two to three times a day according to the severity of the disease of the patient, and 8 g of the medicine is taken for 2 to 3 months continuously each time. Depending on the patient's disease condition, it may be extended for several months to allow adequate disease control and gradual recovery of health.
How does the therapeutic effect of the fukangtong bao pills? According to the body-friendly experience of a plurality of patients on the condition of taking the medicine and the feedback and summary of the patients after taking the medicine, the formula has remarkable curative effect, and the total effective rate reaches one hundred percent. Can quickly relieve or relieve the symptoms of diseases, and patients feel the intra-abdominal and lower-abdominal parts after taking the medicine, have a feeling of promoting qi, often make gurgling and grunting sounds, and have smooth defecation. Patients who do not have menstruation for several months or half a year after taking the medicine generally can get through about ten days, the symptoms of cold abdomen or wind, cold, weakness and numbness of legs can be improved quickly, and the patients feel that the two legs walk forcefully and the body is relaxed. The blood stasis blocks in the uterus of other patients are gradually removed after taking the Fukangtong pill, then the menstruation is continuously drenched, and the symptoms of the menostaxis are gradually recovered to be normal. A plurality of patients with uterine fibroid go to a hospital for instrument detection after taking for 1 to 2 months, and the uterine fibroid is found to have obvious atrophy and decrease by comparing the detection report before taking with the detection report after taking. Patients with partial uterine cancer also feel obvious reduction and improvement after taking the medicine.
What should not be a woman in women's health-promoting pill? Although the Fukangtong pill mainly attacks pathogens and smoothes qi, and strengthens body resistance, the scope of treating gynecological diseases is wide, but there are some diseases that should be prohibited. If a patient has the symptom of serious uterine bleeding, the patient should be prohibited to take the medicine, the patient may be treated by surgical excision as soon as possible because the uterine fibroid is large and the blood vessel is pressed or affected, and the patient is better to take the Fukangtong pill after the bleeding is improved, so that the defect of surgical residues is thoroughly consolidated and recovered and eliminated. In another situation, the medicine should not be taken by the pregnant woman after the pregnant woman finds that the pregnant woman is pregnant, because the pregnant woman mainly has the functions of nourishing blood, tonifying kidney and preventing miscarriage, the medicine mainly has the functions of promoting qi, activating blood, attacking pathogenic factors, killing virus and smoothing fetus and also has the function of strengthening body resistance, after all, the medicines for nourishing blood and preventing miscarriage are few, and the medicine is not suitable for being taken by the pregnant woman after the pregnant woman. If there is blood stasis after delivery, lochiorrhea is the most appropriate.
What is the principle of composition of the formulation? The human body is better than a clear river, and as long as the water is active, the river water can flow without drying. Ancient people also said that: does not decay in running water and is a moth-proof house. Then, take our body to say, the clear water compares to what? Clear water is just the yin and blood of a human body, and the non-deficiency of yin can generate blood actively, so that the blood can not be dried, deficient and sticky, the yin and yang are balanced, the qi and blood are harmonized, and the operation is not blocked, so that the symptoms of qi stagnation and blood stasis, blood stasis and dysmenorrheal, turbid phlegm and damp toxin are not easy to invade, detain and accumulate, and diseases are formed. Therefore, the formula has the functions of nourishing yin, tonifying yang, tonifying qi, nourishing blood and being beneficial to improving the immune system of a human body, and on the basis, the formula can be used for removing waste substances in uterus, including turbid phlegm and blood stasis, killing pathogenic microorganisms and bacteria and viruses, inhibiting the growth of cancer cells, removing blood stasis for promoting tissue regeneration, lowering turbidity, raising yang and purifying the environment in the uterus, so that the qi and blood circulation in the uterus can be recovered and kept smooth, and the effects of removing diseases and treating cancers can be achieved.
The roasted turtle shell has cool nature and the efficacies of nourishing yin and blood, softening hardness and dissipating stagnation, detoxifying and resisting cancer and the like. The turtle shell is rich in keratin, ossein, calcium and iron, can increase the content of hemoglobin, has the function of enriching blood, can soften hardness and dissipate stagnation, can nourish yin and tonify kidney, can nourish blood, has large dosage, and is beneficial to the recovery of gynecological diseases. Concha Ostreae has effects in nourishing yin and blood, softening and resolving hard mass, astringing, and eliminating phlegm. It mainly contains taurine, etc., and can promote secretion of bile, discharge neutral fat accumulated in liver, and improve liver detoxification. The oyster has the functions of softening hard mass, dissipating binds, nourishing yin, tonifying kidney, nourishing blood and eliminating phlegm, so the oyster is very suitable for treating gynecological diseases such as hysteromyoma. Bie Jia and mu Li are used in a certain amount because they can nourish yin, tonify kidney and nourish blood. Concha arcae has effects of softening and resolving hard mass, promoting blood circulation for removing blood stasis, eliminating phlegm, removing turbid pathogen, treating acidity, relieving pain, and resisting ulcer. It contains a large amount of calcium carbonate, a small amount of calcium phosphate, a small amount of magnesium, iron cabinet, silicate, sulfate, chloride and organic matters. It has obvious curative effect on the diseases of blood stasis obstruction of human body, amenorrhea and irregular menstruation of women, etc. The oyster and the concha arcae have the efficacy of eliminating phlegm turbidity and have the effect of treating cyst and hysteromyoma. Radix astragali has effects of invigorating qi, invigorating yang, invigorating defensive system, consolidating superficial resistance, inducing diuresis, relieving swelling, and promoting granulation. It mainly contains astragaloside, astragalus polysaccharide, brass compounds, amino acids, proteins, retinoic acid, folic acid, vitamin D, sitosterol, daucosterol, caffeic acid, chlorogenic acid, trace elements and other components. The astragalus polysaccharide can promote RNA and protein synthesis, promote cell growth, prolong service life, and resist fatigue and influenza virus. Astragalus polysaccharides and saponin have effect of promoting hematopoiesis. The astragalus root can tonify qi and generate blood, and is used for preventing and treating symptoms of hypomenorrhea and the like of women caused by gynecological diseases. The angelica has the functions of promoting blood circulation, removing obstruction in channels, enriching and nourishing blood, and relaxing bowel. It contains rich amino acids and trace elements such as Fe, Ca, Cu, Zn and K, and is favorable to promoting hemopoiesis, enriching blood and raising immunity. The angelica can enrich the blood, regulate menstruation, promote blood circulation, relieve pain, relieve the symptoms of dysmenorrheal, regulate menstruation and prevent the condition of insufficient menstruation caused by gynecological diseases when being taken by women. Radix Morindae officinalis has effects of invigorating kidney, supporting yang, strengthening tendons and bones, and dispelling pathogenic wind and dampness. It contains vitamin C emodin monomethyl ether, palmitic acid, nonadecane, sitosterol, methylisoidin, saccharides, anthraquinones, etc. It can be used for treating kidney yang deficiency, cold limbs, cold pain of lower abdomen, uterus deficiency cold, wind cold dampness, gynecological infection, inflammation, and has antiinflammatory and diuretic effects, and can promote ovarian ovulation, and corpus luteum generation, and maintain corpus luteum function. The three medicines of the roasted turtle shell, the oyster and the concha arcae are simultaneously applied, and have the effects of softening hard masses, dissipating stagnation, removing blood stasis, eliminating phlegm, dissolving tumor and resisting cancer. The five medicines of the roasted turtle shell, the oyster, the astragalus, the angelica and the morinda officinalis are simultaneously applied to play the roles of nourishing yin and tonifying kidney, tonifying qi and nourishing blood, and raising yang and dispelling cold, thereby being beneficial to maintaining normal menstrual flow in the treatment of gynecological diseases and being beneficial to the pregnancy and the birth of children of women.
The Olibanum has effects of promoting blood circulation, activating qi-flowing, removing blood stasis, resisting inflammation, relieving swelling, promoting granulation, and relieving pain. It contains balsam acid, frankincense aliphatic hydrocarbon, olibanic acid, frankincense acid and the like. In addition, the volatile oil is mainly pinene. Has effects in relieving pain, relieving inflammation, increasing leukocyte, accelerating exudation and excretion of inflammation, and promoting wound healing, and the pinene contained therein has effect in eliminating phlegm. Myrrha has effects in promoting blood circulation, activating qi-flowing, relieving swelling and pain, relieving inflammation, and promoting granulation. It contains alpha-bisaboloic acid, B-bisaboloic acid, bisabolol, limonene, bisabolone, etc. It has good antiinflammatory effect, and the water immersion agent has different degrees of inhibiting effect on multiple pathogenic dermatophytes such as trichophyton donovani, trichophyton concentricum, trichophyton schoenleinii and the like in test tube, and the antibacterial effect may be related to the contained eugenol. Rhizoma Sparganii has effects in removing blood stasis, promoting qi circulation, relieving inflammation, and relieving pain. It contains volatile oil, and its main components are phenethyl alcohol, p-benzenediol, hexadecanoic acid, dehydrocostus lactone, succinic acid, sparganiic acid, etc. Has analgesic and leukocyte increasing effects, can promote phagocytic function of monocyte, promote macrophage to gather and phagocytize to blood clot periphery, and has antiinflammatory and analgesic effects on swelling inflammation. It is often used to treat various cysts, myoma, tumor, amenorrhea due to blood stasis, dysmenorrhea, thoracic obstruction, cardiodynia, and abdominal distention and distending pain caused by food stagnation and qi stagnation. Curcumae rhizoma is warm in nature, and has effects of removing blood stasis, activating qi-flowing, resolving food stagnation and relieving pain. It contains volatile oil, brass, terpenes and other chemical components. Mainly comprises zedoary furazolidone, curcumenol, borneol, great cage for animals geraniol, camphor, curcumene, curdione, cinnamomum zeylanicum lactone, daucosterol, B-sitosterol, palmitic acid and other components. Has the functions of anticancer, antibiosis and increasing leucocyte in modern pharmacological research. The zedoary volatile oil can inhibit the growth of staphylococcus aureus, hemolytic streptococcus, escherichia coli, typhoid bacillus, vibrio cholerae and the like in a test tube. Radix Linderae has effects of activating qi-flowing, relieving pain, warming kidney and dispelling cold. Radix linderae is good at dredging qi activity and warming cold evil, so that the radix linderae has good effects of promoting qi circulation, dispelling cold, relieving pain and the like. It can also be used for treating chest and abdomen distending pain caused by cold accumulation and qi stagnation, hernia and abdominal pain caused by cold accumulation and liver meridian, and abdominal pain due to cold can be treated with radix Linderae. Radix aucklandiae is warm in nature, has the important function of regulating qi, and can soothe liver, regulate qi and dredge qi of upper and lower parts. The costus root contains a large amount of volatile oil components, including the taxanes and costunolide, which have good antibacterial effect and can inhibit the growth of streptococcus, golden yellow and staphylococcus albus, and is very suitable for treating gynecological diseases because the costus root has the antibacterial and anti-inflammatory effects and has strong qi regulating effect. Radix Cyathulae is neutral in nature, and has effects of nourishing liver and kidney, removing blood stasis, dredging channels, inducing diuresis, treating stranguria, and relieving joint pain. Radix Cyathulae is good in descending nature and commonly used for activating blood and dredging channels, and removing blood stasis and relieving pain, so it is used for treating gynecological diseases, traumatology diseases and various blood stasis stagnation. It is clinically used for amenorrhea due to blood stagnation, dysmenorrhea, menoxenia, puerperal stagnation and abdominal pain, gynecological tumor, mass, and hematoma and pain due to traumatic injury. The ground beetle has the effects of removing blood stasis, removing stasis, promoting blood circulation, dredging collaterals, regulating wound and the like. Modern pharmacological research shows that the main components of the ground beetle include 17 amino acids such as glutamic acid, 28 trace elements such as arsenic, sterol, straight-chain aliphatic compounds and the like. The ground beetle is rich in amino acids and minerals and has strong effects of promoting blood circulation to remove blood stasis, removing blood stasis to promote tissue regeneration and resisting cancer, so that the ground beetle is very suitable for treating gynecological diseases. The eight medicines of frankincense, myrrh, rhizoma sparganii, curcuma zedoary, combined spicebush root, costustoot, medicinal cyathula root and ground beeltle are simultaneously applied, the acting force of promoting blood circulation to remove blood stasis, promoting qi circulation to relieve pain, removing blood stasis to promote tissue regeneration can be enhanced, and the eight medicines play an important role in removing blood stasis blocks in uterus, purifying the environment in uterus, resisting cyst, hysteromyoma, cancer and the like. Meanwhile, the traditional Chinese medicine composition can play a good role in treating smooth ovarian and fallopian tube blockage, and plays an important role in enabling women to be pregnant.
Galla chinensis has toxic materials removing, anticancer, astringent, hemostatic, sore healing, and repercussive effects. The modern pharmacological research shows that the Chinese gall tannin contains gallnut tannin, gallic acid, acid resin and the like. Galla chinensis tannin can destroy cancer cell prototannin, has anti-tumor effect, and has inhibition rate of more than 90% on mouse sarcoma S-180 and human cervical cancer cell JTC-26. The acid resin has obvious astringency on ulcer of mucous membrane and skin tissue, and the decoction has certain inhibiting or killing effect on staphylococcus aureus, pneumococcus, streptococcus, typhoid bacillus, dysentery bacillus, diphtheria bacillus, anthrax bacillus, pseudomonas aeruginosa, etc. The sargentgloryvine stem has the effects of promoting blood circulation to remove meridian obstruction, detoxifying and removing blood stasis, dispelling wind and killing insects, regulating qi, generating blood and the like. It contains emodin, physcion, B-glycoside sitosterol, daucosterol, stearic acid, salidroside, etc. The traditional Chinese medicine composition is mainly used for treating abdominal pain caused by intestinal carbuncle, pyocutaneous disease caused by heat toxin, urinary system infection, dysmenorrhea, amenorrhea, cyst, hysteromyoma and tumor. Rhizoma Smilacis Glabrae has effects in treating stranguria, eliminating dampness, removing toxic substances, and relieving joint pain. In fact, the glabrous greenbrier rhizome is used for treating severe sore and is said to be an essential drug for treating the syphilis, so the glabrous greenbrier rhizome has a very good treatment effect on the syphilis, vaginitis, gynecological inflammation and yellow belt of women with much peculiar smell. The herba Violae has effects of clearing away heat and toxic materials, cooling blood, and relieving swelling. It is rich in brass components, belongs to polyphenol compounds, and has pharmacological actions in various aspects such as cancer resistance, oxidation resistance and the like. The product also contains multiple trace elements, has effects of clearing away heat and toxic materials, resisting bacteria and diminishing inflammation, and can be used for treating uterine cancer and gynecological inflammation. The Chuanlian has the effects of clearing away heat and toxic materials, cooling blood, relieving swelling, relieving pain, resisting cancer, resisting inflammation and resisting infection. It is used for treating diarrhea, dysentery, stranguria with heat, pain, carbuncle, suppurative sore, dysentery, urinary tract infection, respiratory system infection, traumatic infection, inflammation, swelling and pain, gynecological inflammation, hysteromyoma, and cancer. The herba Scutellariae Barbatae has effects of clearing away heat and toxic materials, resisting bacteria, relieving inflammation, promoting blood circulation, removing blood stasis, resisting cancer, relieving pain, inducing diuresis, and relieving swelling. It is used for treating edema, malignant sore, toxic swelling, hepatitis, gynecological inflammation, hysteromyoma, and carcinoma of uterus. The oldenlandia has the effects of clearing away heat and toxic materials, relieving swelling and pain, promoting blood circulation, promoting urination, astringing, promoting diuresis, resisting inflammation, resisting cancer and the like. It is used for treating chronic bronchitis, rheumatic arthritis, chronic bronchitis, and other cancers. Modern pharmacological research proves that the oldenlandia diffusa can enhance the immunity of organisms and inhibit the growth of tumor cells, and has obvious inhibiting effect on pseudomonas aeruginosa, staphylococcus aureus, pneumococcus and dysentery bacillus. Radix Sophorae Flavescentis has effects of eliminating dampness, removing toxic substance, killing parasite, resisting tumor, resisting allergy, and resisting bacteria. The matrine contained in the sophora flavescens has anticancer activity and has different degrees of inhibition effects on cancer cells. Pharmacological research shows that other alkaloids in radix Sophorae Flavescentis have inhibitory effect on bacterial respiration and nucleic acid metabolism, and have inhibitory effect on Bacillus dysenteriae, Proteus, and Staphylococcus aureus. Cortex Phellodendri has effects of nourishing kidney yin, eliminating deficiency heat, clearing away heat and toxic materials, eliminating dampness, treating sore, resisting ulcer, and resisting cancer. It contains the components of small batlerine, magnoline, volatile oil, stigmasterol, phellodendron copper and so on. Has effects in resisting pathogenic microorganism and protozoa. Has antipyretic, antiinflammatory, expectorant, and antiulcer effects, and can inhibit helicobacter pylori and human type tubercle bacillus. The Chinese gall, the sargentgloryvine stem, the glabrous greenbrier rhizome, the philippine violet herb, the meadowrue root and rhizome, the barbed skullcap herb, the spreading hedyotis herb, the lightyellow sophora root and the amur corktree bark are jointly applied, the acting force of detoxification, dampness elimination, turbid solution removal, inflammation resistance and cancer resistance can be enhanced, only the disease evil causing gynecological diseases can be eliminated, so that the gynecological inflammation, the cyst, the hysteromyoma and the uterine cancer can be gradually improved, the kidney primordial yang qi can be slowly changed into yang, the body yin and yang can be balanced, and the physique can be gradually recovered to be healthy.
In conclusion, all the medicinal compositions of the Fukangtongbao pill are reasonably matched according to the etiology and pathological characteristics of gynecological diseases, and no conflict and adverse reaction occur among the medicaments. The Fukangtongbao pill is mainly used for treating gynecological refractory diseases, and has the main effects of jointly attacking evil, removing stasis, removing turbidity, promoting diuresis, sterilizing, detoxifying, mainly activating qi, nourishing yin, nourishing blood and strengthening yang, and the medicines supplement each other and play a role in synergy to form an acting force for attacking hard mass and relieving bruise for gynecological inflammation, infertility caused by cold womb, cyst, hysteromyoma, uterine cancer and the like. The traditional Chinese medicine composition has obvious and satisfactory treatment efficacy and is a good formula which is difficult to obtain, and has the effects of treating the uterus, purifying the uterus, recovering the health of the uterus, gradually restoring the balance of yin and yang, smoothing the qi movement, harmonizing the qi and blood, and restoring the normal menstruation of women, so that the pregnant women can grow children.
Claims (2)
1. The invention relates to a Chinese medicinal formula, which is a Fukangtong pill for treating: the formula composition of gynecological inflammation, infertility due to cold womb, cyst, hysteromyoma and uterine cancer comprises the following components: 70 g of roasted turtle shell, 60 g of oyster, 50 g of astragalus root, 60 g of angelica, 60 g of morinda officinalis, 60 g of concha arcae, 50 g of frankincense, 40 g of myrrh, 40 g of rhizoma sparganii, 40 g of curcuma zedoary, 50 g of radix linderae, 60 g of elecampane, 30 g of medicinal cyathula root, 20 g of ground beetle, 40 g of Chinese gall, 30 g of sargentgloryvine stem, 30 g of glabrous greenbrier rhizome, 30 g of philippine violet herb, 30 g of meadowrue root and rhizome, 20 g of barbed skullcap herb, 30 g of spreading hedyotis herb, 50 g of sophora flavescens, 50 g of phellodendron bark and the like.
2. The preparation method comprises five steps
Firstly, mixing the medicines together according to a formula
Secondly, the mixed traditional Chinese medicines are pulverized into fine powder of 200 meshes by a pulverizer
Thirdly, adding a proper amount of starch paste prepared by corn starch as an adhesive, and fully and uniformly stirring
Fourthly, putting the fine powder which is evenly stirred into a full-automatic pill making machine to prepare water pills
And fifthly, filling the prepared water-bindered pills into a dryer and drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617724.0A CN114028517A (en) | 2021-06-02 | 2021-06-02 | Fukangtong pill for women |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617724.0A CN114028517A (en) | 2021-06-02 | 2021-06-02 | Fukangtong pill for women |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114028517A true CN114028517A (en) | 2022-02-11 |
Family
ID=80134214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110617724.0A Pending CN114028517A (en) | 2021-06-02 | 2021-06-02 | Fukangtong pill for women |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028517A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1500501A (en) * | 2002-11-12 | 2004-06-02 | 王红波 | Compound traditional Chinese medicine formulation for curing hysteromyoma |
CN104887983A (en) * | 2015-05-13 | 2015-09-09 | 於朝琴 | Traditional Chinese medicine formula for treating gynecological disease and preparing method of traditional Chinese medicine formula for treating gynecological disease |
CN105012894A (en) * | 2015-08-21 | 2015-11-04 | 熊玉雪 | Traditional Chinese medicine for treating gynaecological diseases |
-
2021
- 2021-06-02 CN CN202110617724.0A patent/CN114028517A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1500501A (en) * | 2002-11-12 | 2004-06-02 | 王红波 | Compound traditional Chinese medicine formulation for curing hysteromyoma |
CN104887983A (en) * | 2015-05-13 | 2015-09-09 | 於朝琴 | Traditional Chinese medicine formula for treating gynecological disease and preparing method of traditional Chinese medicine formula for treating gynecological disease |
CN105012894A (en) * | 2015-08-21 | 2015-11-04 | 熊玉雪 | Traditional Chinese medicine for treating gynaecological diseases |
Non-Patent Citations (4)
Title |
---|
叶玉妹: "消症合剂治疗子宫内膜异位症43例", 实用中医药杂志, vol. 17, no. 05, pages 1 * |
张小华;等: "丹黄祛瘀胶囊配合超短波治疗盆腔炎100例", 陕西中医学院学报, vol. 31, no. 04, pages 47 - 48 * |
蒋继芳: "莪棱消瘤汤治疗子宫肌瘤60例疗效观察", 山东中医杂志, vol. 21, no. 04, pages 215 * |
赵英: "桂枝茯苓丸治疗妇科病临床研究", 河北中医药学报, vol. 31, no. 01, pages 30 - 31 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105560662A (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis | |
CN102488814B (en) | Chinese medicinal composition for treating bovine mastitis | |
CN106138733A (en) | One treats dermopathic Chinese medicinal ointment preparation and preparation method thereof | |
CN101658657B (en) | Drug for treating chronic cholecystitis | |
CN103520439A (en) | Traditional Chinese medicine for treating heat-toxicity accumulation type chronic osteomyelitis and preparation method thereof | |
CN105412867A (en) | Chinese and western medicine for gynecology and obstetrics surgery and preparation method thereof | |
CN114028517A (en) | Fukangtong pill for women | |
CN113181318A (en) | Traditional Chinese medicine ointment for treating haemorrhoids and preparation method thereof | |
CN104825598A (en) | External-use plaster for treating rheumatic bone pain and preparation method thereof | |
CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
CN104324114A (en) | Traditional Chinese medicine preparation for treating dysentery | |
CN1682886A (en) | External application Chinese medicine composition for treating rheumatism, rheumatoid diseases and chronic pain | |
CN103893517A (en) | Traditional Chinese medicinal mixture for treating dermatitis and eczema | |
CN114028519A (en) | Wushe Xiaofeng Wan (Wushe Xiaofeng Wan) | |
CN114028486A (en) | Propolis stomach invigorating pill | |
CN114010741A (en) | Pill for treating prostatitis | |
CN105770538A (en) | Traditional Chinese medicine for treating local vascular access induration of hemodialysis patients | |
CN105106533A (en) | Traditional Chinese medicine composition for treating gestational gallstones | |
CN114010713A (en) | Kidney failure recovery pill | |
CN105596852A (en) | Ointment for treating bromhidrosis and preparation method thereof | |
CN104524204A (en) | Traditional Chinese medicine preparation for treating wounds and malignant sores and preparation method of traditional Chinese medicine preparation | |
CN112915171A (en) | Gout treating ball | |
CN103638506B (en) | A kind of Chinese medicine for the treatment of arthromyodynia | |
CN104436043A (en) | Analgesic anti-inflammatory ointment for treating sore and ulcer yang syndrome and preparation method thereof | |
CN104435529A (en) | Externally-applied preparation for treating traumatic injury and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Fengyu Document name: Notification of qualified procedures |
|
DD01 | Delivery of document by public notice | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |